Who owns IOVA?
Institutional ownership of Iovance Biotherapeutics Inc. from Form 13F, Q2 2026
292 institutional managers reported holding Iovance Biotherapeutics Inc. (IOVA) in Form 13F filings for Q2 2026, with 286,782,846 shares worth $1.2B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 17,648,925 shares (+6.6%). 42 opened new positions and 35 sold out.
- Funds holding
- 292
- Value held
- $1.2B
- New / sold out
- 42 / 35
- Net shares, same filers
- +6.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IOVA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $154M | 12.9% | 36,957,681 | Added |
| MHR Fund Management LLC | $121M | 10.1% | 28,967,103 | Unchanged |
| State Street Corp | $102M | 8.5% | 24,478,268 | Added |
| Two Sigma Investments, LP | $79.1M | 6.6% | 19,010,697 | Added |
| Vanguard Capital Management LLC | $75.7M | 6.3% | 18,204,248 | Added |
| Vanguard Portfolio Management LLC | $59.9M | 5.0% | 14,388,999 | Added |
| Geode Capital Management, LLC | $43.0M | 3.6% | 10,324,826 | Added |
| Millennium Management LLC | $35.5M | 3.0% | 8,525,919 | Trimmed |
| Dimensional Fund Advisors LP | $26.9M | 2.3% | 6,460,449 | Added |
| Palo Alto Investors LP | $22.0M | 1.8% | 5,296,209 | Trimmed |
| Goldman Sachs Group Inc | $21.2M | 1.8% | 5,096,334 | Trimmed |
| Nuveen, LLC | $20.8M | 1.7% | 4,997,112 | Added |
| Bank of America Corp | $20.8M | 1.7% | 4,993,584 | Trimmed |
| Morgan Stanley | $20.7M | 1.7% | 4,986,461 | Trimmed |
| Jupiter Asset Management LTD | $18.9M | 1.6% | 4,535,080 | New |
| Jane Street Group, LLC | $18.3M | 1.5% | 4,393,853 | Added |
| Northern Trust Corp | $17.3M | 1.4% | 4,154,200 | Added |
| AQR Capital Management LLC | $16.1M | 1.3% | 3,869,584 | Added |
| Wells Fargo & Company | $13.5M | 1.1% | 3,246,537 | Added |
| Charles Schwab Investment Management Inc | $13.4M | 1.1% | 3,219,656 | Added |
| HRT Financial LP | $12.9M | 1.1% | 3,097,787 | Trimmed |
| Susquehanna International Group, LLP | $11.1M | 0.9% | 2,656,740 | Trimmed |
| Vanguard Fiduciary Trust Co | $10.6M | 0.9% | 2,542,878 | Added |
| JPMorgan Chase & Co | $10.2M | 0.8% | 2,431,616 | Trimmed |
| Price T Rowe Associates Inc | $10.1M | 0.8% | 2,415,456 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 286,782,846 IOVA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- State Street Corp Added+$29.2M
- BlackRock, Inc. Added+$24.4M
- Two Sigma Investments, LP Added+$22.1M
- Jupiter Asset Management LTD New+$18.9M
- Dimensional Fund Advisors LP Added+$15.9M
- AQR Capital Management LLC Added+$13.5M
- Vanguard Portfolio Management LLC Added+$11.2M
- Xcelsior Advisor Partners LLC Added+$7.4M
- Geode Capital Management, LLC Added+$7.3M
- Vanguard Capital Management LLC Added+$6.6M
Biggest sellers in Q2 2026
- Invenomic Capital Management LP Trimmed-$29.2M
- D. E. Shaw & Co., Inc. Trimmed-$24.4M
- Goldman Sachs Group Inc Trimmed-$15.2M
- Bank of America Corp Trimmed-$14.5M
- Marshall Wace, LLP Trimmed-$9.6M
- Morgan Stanley Trimmed-$5.1M
- Palo Alto Investors LP Trimmed-$4.4M
- Millennium Management LLC Trimmed-$3.7M
- Soleus Capital Management, L.P. Trimmed-$3.5M
- Price T Rowe Associates Inc Trimmed-$3.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $218M and sold $143M; 129 added and 62 trimmed.
Schedule 13D and 13G filings on IOVA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Iovance Biotherapeutics Inc.Schedule 13G
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by Iovance Biotherapeutics Inc.Schedule 13G
- 2026-05-12STATE STREET CORP SCHEDULE 13G filed by Iovance Biotherapeutics Inc.Schedule 13G
- 2026-02-09STATE STREET CORP SCHEDULE 13G filed by Iovance Biotherapeutics Inc.Schedule 13G
Questions about IOVA ownership
- Who owns IOVA stock?
- 292 institutional investment managers reported IOVA positions in their Form 13F filings for Q2 2026, holding 286,782,846 shares worth $1.2B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling IOVA?
- In Q2 2026, 42 managers opened new IOVA positions, 129 added, 62 trimmed and 35 sold out. Managers that filed in both quarters added a net 17,648,925 shares.
- How current is this IOVA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IOVA by CUSIP. Options are left out. IOVA news and filings · IOVA insider trades · Top funds